[July 21, 2011]

Research and Markets: 'Onchocerciasis (River Blindness): Pipeline Review, Q2 2011' - Latest News and Deals Relating to the Products

Research and Markets (http://www.researchandmarkets.com/research/efb3c5/onchocerciasis_ri) has announced the addition of Global Markets Direct's new report "Onchocerciasis (River Blindness) - Pipeline Review, Q2 2011" to their offering.

'Onchocerciasis (River Blindness) - Pipeline Review, Q2 2011Onchocerciasis (River Blindness) - Pipeline Review, Q2 2011' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC (News - Alert) filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources,

Scope

• A snapshot of the global therapeutic scenario for Onchocerciasis (River Blindness).
• A review of the Onchocerciasis (River Blindness) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
• Coverage of products based on various stages of development ranging from discovery till registration stages.
• A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
• Coverage of the Onchocerciasis (River Blindness) pipeline on the basis of therapeutic class, route of administration and molecule type.
• Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
• Key discontinued pipeline projects.
• Latest news and deals relating to the products.

For more information visit http://www.researchandmarkets.com/research/efb3c5/onchocerciasis_ri

[ Back To TMCnet.com's Homepage ]